Osimertinib Mesylate

Osimertinib Mesylate

Osimertinib is a covalent, orally active, irreversible EGFR inhibitor that selectively targets mutant EGFR with IC50s of 12 nM for L858R and 1 nM for L858R/T790M. It effectively overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Osimertinib mesylate is used for the treatment of EGFR-mutated non-small-cell lung cancer, demonstrating potent antitumor activity. Reagent grade, for research use only.

Molecular structure of the compound BP-43647
    • Unit
    • Price
    • Qty
    • 1 G
    • $90.00
    • 5 G
    • $210.00
    • 10 G
    • $320.00
    • 25 G
    • $540.00

Usually ships within 24 hours.

Would you like to inquire about custom quantity?
Inquire